Cargando…
Bisphosphonate Treatment in a Patient Affected by MPS IVA with Osteoporotic Phenotype
Morquio A syndrome (Mucopolysaccharidosis type IVA) (MPS IVA) is a rare inherited metabolic disorder characterized by the defective degradation of keratan sulfate and chondroitin-6-sulfate. Classically, MPS IVA patients present with severe multisystemic involvement and have a short life expectancy....
Autores principales: | Tummolo, Albina, Gabrielli, Orazio, Gaeta, Alberto, Masciopinto, Maristella, Zampini, Lucia, Pavone, Luigi Michele, Di Natale, Paola, Papadia, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855944/ https://www.ncbi.nlm.nih.gov/pubmed/24348578 http://dx.doi.org/10.1155/2013/891596 |
Ejemplares similares
-
Long-term continuous N-carbamylglutamate treatment in frequently decompensated propionic acidemia: a case report
por: Tummolo, Albina, et al.
Publicado: (2018) -
Food Habits and Lifestyle in Hyperphenylalaninemia Patients: Should These Be Monitored?
por: Dicintio, Annamaria, et al.
Publicado: (2022) -
Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance
por: Akyol, Mehmet Umut, et al.
Publicado: (2019) -
Addressing the need for patient-friendly medical communications: adaptation of the 2019 recommendations for the management of MPS VI and MPS IVA
por: Bruce, Iain A., et al.
Publicado: (2022) -
Cardiac involvement in MPS patients: incidence and response to therapy in an Italian multicentre study
por: Sestito, Simona, et al.
Publicado: (2022)